TY - JOUR AU - Sonpavde, G. AU - Hutson, T. E. PY - 2007 DA - 2007// TI - Pazopanib: a novel multitargeted tyrosine kinase inhibitor JO - Curr Oncol Rep VL - 9 UR - https://doi.org/10.1007/s11912-007-0007-2 DO - 10.1007/s11912-007-0007-2 ID - Sonpavde2007 ER - TY - JOUR AU - Graaf, W. T. AU - Blay, J. Y. AU - Chawla, S. P. AU - Kim, D. W. AU - Bui-Nguyen, B. AU - Casali, P. G. PY - 2012 DA - 2012// TI - Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial JO - Lancet VL - 379 UR - https://doi.org/10.1016/S0140-6736(12)60651-5 DO - 10.1016/S0140-6736(12)60651-5 ID - Graaf2012 ER - TY - STD TI - Votrient (pazopanib) [prescribing information] https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022465lbl.pdf. Accessed 6 Sept 2018. UR - https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022465lbl.pdf ID - ref3 ER - TY - STD TI - Votrient [Summary of Product characteristics] http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/001141/WC500094272.pdf. Accessed 6 Sept 2018. UR - http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/001141/WC500094272.pdf ID - ref4 ER - TY - JOUR AU - Nijhuis, P. H. AU - Schaapveld, M. AU - Otter, R. AU - Molenaar, W. M. AU - Graaf, W. T. AU - Hoekstra, H. J. PY - 1999 DA - 1999// TI - Epidemiological aspects of soft tissue sarcomas (STS)--consequences for the design of clinical STS trials JO - Eur J Cancer VL - 35 UR - https://doi.org/10.1016/S0959-8049(99)00152-5 DO - 10.1016/S0959-8049(99)00152-5 ID - Nijhuis1999 ER - TY - JOUR AU - Biau, D. J. AU - Ferguson, P. C. AU - Turcotte, R. E. AU - Chung, P. AU - Isler, M. H. AU - Riad, S. PY - 2011 DA - 2011// TI - Adverse effect of older age on the recurrence of soft tissue sarcoma of the extremities and trunk JO - J Clin Oncol VL - 29 UR - https://doi.org/10.1200/JCO.2010.34.0711 DO - 10.1200/JCO.2010.34.0711 ID - Biau2011 ER - TY - JOUR AU - Hoven-Gondrie, M. L. AU - Bastiaannet, E. AU - Ho, V. K. AU - Leeuwen, B. L. AU - Liefers, G. J. AU - Hoekstra, H. J. PY - 2016 DA - 2016// TI - Worse survival in elderly patients with extremity soft-tissue sarcoma JO - Ann Surg Oncol VL - 23 UR - https://doi.org/10.1245/s10434-016-5158-7 DO - 10.1245/s10434-016-5158-7 ID - Hoven-Gondrie2016 ER - TY - JOUR AU - Lev, D. AU - Pollock, R. E. PY - 2010 DA - 2010// TI - Managing elderly soft tissue sarcoma patients-should age drive treatment? JO - Ann Surg Oncol VL - 17 UR - https://doi.org/10.1245/s10434-010-1035-y DO - 10.1245/s10434-010-1035-y ID - Lev2010 ER - TY - JOUR AU - Garbay, D. AU - Maki, R. G. AU - Blay, J. Y. AU - Isambert, N. AU - Piperno Neumann, S. AU - Blay, C. PY - 2013 DA - 2013// TI - Advanced soft-tissue sarcoma in elderly patients: patterns of care and survival JO - Ann Oncol VL - 24 UR - https://doi.org/10.1093/annonc/mdt059 DO - 10.1093/annonc/mdt059 ID - Garbay2013 ER - TY - JOUR AU - Hutchins, L. F. AU - Unger, J. M. AU - Crowley, J. J. AU - Coltman, C. A. AU - Albain, K. S. PY - 1999 DA - 1999// TI - Underrepresentation of patients 65 years of age or older in cancer-treatment trials JO - N Engl J Med VL - 341 UR - https://doi.org/10.1056/NEJM199912303412706 DO - 10.1056/NEJM199912303412706 ID - Hutchins1999 ER - TY - JOUR AU - Subbiah, V. AU - Hess, K. R. AU - Khawaja, M. R. AU - Wagner, M. J. AU - Tang, C. AU - Naing, A. PY - 2016 DA - 2016// TI - Evaluation of novel targeted therapies in aggressive biology sarcoma patients after progression from US FDA approved therapies JO - Sci Rep VL - 6 UR - https://doi.org/10.1038/srep35448 DO - 10.1038/srep35448 ID - Subbiah2016 ER - TY - JOUR AU - Cesne, A. L. AU - Judson, I. AU - Maki, R. AU - Grosso, F. AU - Schuetze, S. AU - Mehren, M. V. PY - 2013 DA - 2013// TI - Trabectedin is a feasible treatment for soft tissue sarcoma patients regardless of patient age: a retrospective pooled analysis of five phase II trials JO - Br J Cancer VL - 109 UR - https://doi.org/10.1038/bjc.2013.524 DO - 10.1038/bjc.2013.524 ID - Cesne2013 ER - TY - JOUR AU - Duffaud, F. AU - Ray-Coquard, I. AU - Marchal, F. AU - Chaigneau, L. AU - Bouche, O. AU - Huynh, T. K. PY - 2013 DA - 2013// TI - Clinical experience with sunitinib (SU) in patients over age 65 with metastatic gastrointestinal stromal tumors (GIST): a retrospective study from the French sarcoma group (FSG) JO - J Clin Oncol VL - 31 ID - Duffaud2013 ER - TY - JOUR AU - Ray-Coquard, I. AU - Collard, O. AU - Ducimetiere, F. AU - Laramas, M. AU - Mercier, F. AU - Ladarre, N. PY - 2017 DA - 2017// TI - Treatment patterns and survival in an exhaustive French cohort of pazopanib-eligible patients with metastatic soft tissue sarcoma (STS) JO - BMC Cancer VL - 17 UR - https://doi.org/10.1186/s12885-017-3057-3 DO - 10.1186/s12885-017-3057-3 ID - Ray-Coquard2017 ER - TY - JOUR AU - Grünwald, V. i. k. t. o. r. AU - Kunitz, A. n. n. e. g. r. e. t. AU - Schuler, M. a. r. k. u. s. K. a. j. o. AU - Schoffski, P. a. t. r. i. c. k. AU - Kopp, H. a. n. s. -. G. e. o. r. g. AU - Bauer, S. e. b. a. s. t. i. a. n. AU - Kasper, B. e. r. n. d. AU - Lindner, L. a. r. s. H. AU - Chemnitz, J. e. n. s. -. M. a. r. c. u. s. AU - Crysandt, M. a. r. t. i. n. a. M. a. r. g. r. i. t. AU - Stein, A. l. e. x. a. n. d. e. r. AU - Steffen, B. j. o. e. r. n. AU - Egerer, G. e. r. l. i. n. d. e. AU - Zimmermann, S. i. l. k. e. AU - Karch, A. n. n. i. k. a. PY - 2018 DA - 2018// TI - Randomized comparison of pazopanib (PAZ) and doxorubicin (DOX) in the first line treatment of metastatic soft tissue sarcoma (STS) in elderly patients (pts): Results of a phase II study (EPAZ) JO - Journal of Clinical Oncology VL - 36 UR - https://doi.org/10.1200/JCO.2018.36.15_suppl.11506 DO - 10.1200/JCO.2018.36.15_suppl.11506 ID - Grünwald2018 ER - TY - JOUR AU - Bolli, N. AU - Avet-Loiseau, H. AU - Wedge, D. C. AU - Loo, P. AU - Alexandrov, L. B. AU - Martincorena, I. PY - 2014 DA - 2014// TI - Heterogeneity of genomic evolution and mutational profiles in multiple myeloma JO - Nat Commun VL - 5 UR - https://doi.org/10.1038/ncomms3997 DO - 10.1038/ncomms3997 ID - Bolli2014 ER - TY - JOUR AU - Johnson, B. E. AU - Mazor, T. AU - Hong, C. AU - Barnes, M. AU - Aihara, K. AU - McLean, C. Y. PY - 2014 DA - 2014// TI - Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma JO - Science VL - 343 UR - https://doi.org/10.1126/science.1239947 DO - 10.1126/science.1239947 ID - Johnson2014 ER - TY - JOUR AU - Qazi, M. A. AU - Vora, P. AU - Venugopal, C. AU - Sidhu, S. S. AU - Moffat, J. AU - Swanton, C. PY - 2017 DA - 2017// TI - Intratumoral heterogeneity: pathways to treatment resistance and relapse in human glioblastoma JO - Ann Oncol VL - 28 UR - https://doi.org/10.1093/annonc/mdx169 DO - 10.1093/annonc/mdx169 ID - Qazi2017 ER - TY - JOUR AU - Burrell, R. A. AU - Swanton, C. PY - 2014 DA - 2014// TI - Tumour heterogeneity and the evolution of polyclonal drug resistance JO - Mol Oncol VL - 8 UR - https://doi.org/10.1016/j.molonc.2014.06.005 DO - 10.1016/j.molonc.2014.06.005 ID - Burrell2014 ER - TY - JOUR AU - Grassi, P. AU - Verzoni, E. AU - Ratta, R. AU - Porcu, L. AU - Prisciandaro, M. AU - Mennitto, A. PY - 2017 DA - 2017// TI - Does dose modification affect efficacy of first-line pazopanib in metastatic renal cell carcinoma? JO - Drugs R D VL - 17 UR - https://doi.org/10.1007/s40268-017-0203-y DO - 10.1007/s40268-017-0203-y ID - Grassi2017 ER - TY - JOUR AU - Bjarnason, G. A. AU - Kollmannsberger, C. K. AU - Ahmad, Q. AU - Dezzani, L. AU - Elmeliegy, M. AU - Han, J. PY - 2017 DA - 2017// TI - Effects of pazopanib (PAZ) and sunitinib (SUN) dose modification on safety and efficacy in patients with metastatic renal cell carcinoma (mRCC) from COMPARZ JO - J Clin Oncol VL - 35 UR - https://doi.org/10.1200/JCO.2017.35.15_suppl.4574 DO - 10.1200/JCO.2017.35.15_suppl.4574 ID - Bjarnason2017 ER - TY - JOUR AU - Shah, D. R. AU - Shah, R. R. AU - Morganroth, J. PY - 2013 DA - 2013// TI - Tyrosine kinase inhibitors: their on-target toxicities as potential indicators of efficacy JO - Drug Saf VL - 36 UR - https://doi.org/10.1007/s40264-013-0050-x DO - 10.1007/s40264-013-0050-x ID - Shah2013 ER - TY - JOUR AU - Suttle, A. B. AU - Ball, H. A. AU - Molimard, M. AU - Hutson, T. E. AU - Carpenter, C. AU - Rajagopalan, D. PY - 2014 DA - 2014// TI - Relationships between pazopanib exposure and clinical safety and efficacy in patients with advanced renal cell carcinoma JO - Br J Cancer VL - 111 UR - https://doi.org/10.1038/bjc.2014.503 DO - 10.1038/bjc.2014.503 ID - Suttle2014 ER -